The role of soluble fiber intake in patients under highly effective lipid-lowering therapy

Nutrition Journal

Volumn 10, Issue 1, 2011, Pages

  Ramos, Silvia C ^a   Fonseca, Francisco A ^a   Kasmas, Soraia H ^a   Moreira, Flávio T ^a   Helfenstein, Tatiana ^a   Borges, Ney C ^b   Moreno, Ronilson A ^b   Rezende, Vinicius M ^b   Silva, Fernanda C ^b   Izar, Maria C ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b Synchrophar Analitica   (Brazil)

Author keywords

campesterol; desmosterol; lipid lowering therapy; lipids; Soluble fiber

Indexed keywords

CAMPESTEROL; CHOLESTEROL; DESMOSTEROL; EZETIMIBE; EZETIMIBE PLUS SIMVASTATIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ROSUVASTATIN; SITOSTEROL; STEROL; TRIACYLGLYCEROL; AZETIDINE DERIVATIVE; DRUG DERIVATIVE; FLUOROBENZENE; PHYTOSTEROL; PYRIMIDINE DERIVATIVE; SITOSTEROL DERIVATIVE; SULFONAMIDE;

ARTICLE; BLOOD SAMPLING; BODY MASS; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; DIETARY INTAKE; DOUBLE BLIND PROCEDURE; FEMALE; FIBER; FOOD INTAKE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; MALE; OPEN STUDY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; WEIGHT REDUCTION; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIET THERAPY; DIETARY FIBER; DISORDERS OF LIPID AND LIPOPROTEIN METABOLISM; DRUG EFFECT; ENTEROPATHY; MIDDLE AGED; SITOSTEROLEMIA;

AZETIDINES; BLOOD GLUCOSE; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIETARY FIBER; FEMALE; FLUOROBENZENES; HUMANS; HYPERCHOLESTEROLEMIA; INTESTINAL DISEASES; LIPID METABOLISM, INBORN ERRORS; MALE; MIDDLE AGED; PHYTOSTEROLS; PYRIMIDINES; SITOSTEROLS; SULFONAMIDES; TRIGLYCERIDES;

EID: 79960890191     PISSN: None     EISSN: 14752891     Source Type: Journal    
DOI: 10.1186/1475-2891-10-80     Document Type: Article

References (36)

1. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002 106 25 3143 421 12485966
2. Improvement of cholesterol levels and reduction of cardiovascular risk via the consumption of phytosterols. Ortega RM, Palencia A, Lopez-Sobaler AM, Br J Nutr 2006 96 Suppl 1 89 93 16923260
3. Water-soluble dietary fibers and cardiovascular disease. Theuwissen E, Mensink RP, Physiol Behav 2008 94 2 285 92 10.1016/j.physbeh.2008.01.001 18302966 (Pubitemid 351615430)
4. Plasma sitosterol elevations are associated with an increased incidence of coronary events in men: results of a nested case-control analysis of the Prospective Cardiovascular Munster (PROCAM) study. Assmann G, Cullen P, Erbey J, Ramey DR, Kannenberg F, Schulte H, Nutr Metab Cardiovasc Dis 2006 16 1 13 21 10.1016/j.numecd.2005.04.001 16399487
5. Phytosterols and vascular disease. Patel MD, Thompson PD, Atherosclerosis 2006 186 1 12 9 10.1016/j.atherosclerosis.2005.10.026 16325823
6. Association between dietary fiber and serum C-reactive protein. Ma Y, Griffith JA, Chasan-Taber L, Olendzki BC, Jackson E, Stanek EJ, Li W, Pagoto SL, Hafner AR, Ockene IS, Am J Clin Nutr 2006 83 4 760 6 16600925 (Pubitemid 44713137)
7. Comparison of the effects of high doses of rosuvastatin versus atorvastatin on the subpopulations of high-density lipoproteins. Asztalos BF, Le Maulf F, Dallal GE, Stein E, Jones PH, Horvath KV, McTaggart F, Schaefer EJ, Am J Cardiol 2007 99 5 681 5 10.1016/j.amjcard.2006.09.117 17317371
8. Comparison of the effects of maximal dose atorvastatin and rosuvastatin therapy on cholesterol synthesis and absorption markers. van Himbergen TM, Matthan NR, Resteghini NA, Otokozawa S, Ai M, Stein EA, Jones PH, Schaefer EJ, J Lipid Res 2009 50 4 730 9 19043140
9. Lipid-altering efficacy of the ezetimibe/simvastatin single tablet versus rosuvastatin in hypercholesterolemic patients. Catapano AL, Davidson MH, Ballantyne CM, Brady WE, Gazzara RA, Tomassini JE, Tershakovec AM, Curr Med Res Opin 2006 22 10 2041 53 10.1185/030079906X132721 17022864 (Pubitemid 44663409)
10. Scandinavian simvastatin study (4S). Grodos D, Tonglet R, Lancet 1994 344 8939-8940 1768 10.1016/S0140-6736(94)92907-6 7997018
11. Serum noncholesterol sterols during inhibition of cholesterol synthesis by statins. Miettinen TA, Gylling H, Lindbohm N, Miettinen TE, Rajaratnam RA, Relas H, J Lab Clin Med 2003 141 2 131 7 10.1067/mlc.2003.9 12577049 (Pubitemid 36216566)
12. Common sequence variations in ABCG8 are related to plant sterol metabolism in healthy volunteers. Plat J, Bragt MC, Mensink RP, J Lipid Res 2005 46 1 68 75 15520451 (Pubitemid 40066672)
13. Zetia: inhibition of Niemann-Pick C1 Like 1 (NPC1L1) to reduce intestinal cholesterol absorption and treat hyperlipidemia. Davis HR, Veltri EP, J Atheroscler Thromb 2007 14 3 99 108 10.5551/jat.14.99 17587760
14. Serum noncholesterol sterols during inhibition of cholesterol synthesis by statins. Miettinen TA, Gylling H, Lindbohm N, Miettinen TE, Rajaratnam RA, Relas H, Finnish Treat-to-Target Study Investigators, J Lab Clin Med 2003 141 2 131 7 10.1067/mlc.2003.9 12577049 (Pubitemid 36216566)
15. Cholesterol synthesis and absorption in coronary patients with lipid triad and isolated high LDL cholesterol in a 4S subgroup. Miettinen TA, Gylling H, Atherosclerosis 2003 168 2 343 9 10.1016/S0021-9150(03)00106-0 12801618 (Pubitemid 36703334)
16. Effects of ezetimibe, simvastatin, atorvastatin, and ezetimibe-statin therapies on non-cholesterol sterols in patients with primary hypercholesterolemia. Assmann G, Kannenberg F, Ramey DR, Musliner TA, Gutkin SW, Veltri EP, Curr Med Res Opin 2008 24 1 249 59 10.1185/030079908X253663 18053317 (Pubitemid 351160257)
17. Alterations in cholesterol absorption/synthesis markers characterize Framingham offspring study participants with CHD. Matthan NR, Pencina M, LaRocque JM, Jacques PF, D'Agostino RB, Schaefer EJ, Lichtenstein AH, J Lipid Res 2009 50 9 927 35
18. Comparison of dietary assessment methods in nutritional epidemiology: weighed records v. Bingham SA, Gill C, Welch A, Day K, Cassidy A, Khaw KT, Sneyd MJ, Key TJ, Roe L, Day NE, 24 h recalls, food-frequency questionnaires and estimated-diet records. Br J Nutr 1994 72 4 619 43
19. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Friedewald WT, Levy RI, Fredrickson DS, Clin Chem 1972 18 6 499 502 4337382
20. Position of the American Dietetic Association: health implications of dietary fiber. Marlett JA, McBurney MI, Slavin JL, J Am Diet Assoc 2002 102 7 993 1000 10.1016/S0002-8223(02)90228-2 12146567 (Pubitemid 40434172)
21. Cholesterol-lowering effects of dietary fiber: a meta-analysis. Brown L, Rosner B, Willett WW, Sacks FM, Am J Clin Nutr 1999 69 1 30 42 9925120 (Pubitemid 29031248)
22. Health benefits of dietary fiber. Anderson JW, Baird P, Davis RH Jr, Ferreri S, Knudtson M, Koraym A, Waters V, Williams CL, Nutr Rev 2009 67 4 188 205 10.1111/j.1753-4887.2009.00189.x 19335713
23. Dietary fiber, lipids and atherosclerosis. Anderson JW, Am J Cardiol 1987 60 12 17G 22G 10.1016/0002-9149(87)90587-X 2823590 (Pubitemid 17164561)
24. Serum sterols during stanol ester feeding in a mildly hypercholesterolemic population. Gylling H, Puska P, Vartiainen E, Miettinen TA, J Lipid Res 1999 40 4 593 600 10191283 (Pubitemid 29173762)
25. Effects of plant stanol and sterol esters on serum phytosterols in a family with familial hypercholesterolemia including a homozygous subject. Ketomaki A, Gylling H, Miettinen TA, J Lab Clin Med 2004 143 4 255 62 10.1016/j.lab.2003.11.007 15085084 (Pubitemid 38510121)
26. The effects of statins and sitosterols: benefit or not? Miettinen TA, Gylling H, Curr Atheroscler Rep 2009 11 1 23 7 10.1007/s11883-009-0004-z 19080724
27. Niemann-Pick C1 Like 1 (NPC1L1) an intestinal sterol transporter. Davis HR Jr, Altmann SW, Biochim Biophys Acta 2009 1791 7 679 83 19272334
28. Effect of two doses of a mixture of soluble fibres on body weight and metabolic variables in overweight or obese patients: a randomised trial. Salas-Salvado J, Farres X, Luque X, Narejos S, Borrell M, Basora J, Anguera A, Torres F, Bullá M, Balanza R, Fiber in Obesity-Study Group, Br J Nutr 2008 99 6 1380 7 18031592
29. Increasing total fiber intake reduces risk of weight and fat gains in women. Tucker LA, Thomas KS, J Nutr 2009 139 3 576 81 10.3945/jn.108.096685 19158230
30. Fiber facts: benefits and recommendations for individuals with type 2 diabetes. Vuksan V, Rogovik AL, Jovanovski E, Jenkins AL, Curr Diab Rep 2009 9 5 405 11 10.1007/s11892-009-0062-1 19793511
31. Beta-glucan from two sources of oat concentrates affect postprandial glycemia in relation to the level of viscosity. Panahi S, Ezatagha A, Temelli F, Vasanthan T, Vuksan V, J Am Coll Nutr 2007 26 6 639 44 18187427
32. Dietary fibers: current trends and health benefits in the metabolic syndrome and type 2 diabetes. Mello VD, Laaksonen DE, Arq Bras Endocrinol Metabol 2009 53 5 509 18 10.1590/S0004-27302009000500004 19768242
33. Glucose and insulin responses to whole grain breakfasts varying in soluble fiber, beta-glucan: a dose response study in obese women with increased risk for insulin resistance. Kim H, Stote KS, Behall KM, Spears K, Vinyard B, Conway JM, Eur J Nutr 2009 48 3 170 5 10.1007/s00394-009-0778-3 19205780
34. Statin therapy and risk of developing type 2 diabetes: a meta-analysis. Rajpathak SN, Kumbhani DJ, Crandall J, Barzilai N, Alderman M, Ridker PM, Diabetes Care 2009 32 10 1924 9 10.2337/dc09-0738 19794004
35. Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials. Sattar N, Preiss D, Murray HM, Paul Welsh, Brendan Buckley M, Anton de Craen JM, Sreenivasa Rao Kondapally Seshasai, John McMurray J, Dilys Freeman J, Wouter Jukema J, Peter Macfarlane W, Chris Packard J, David Stott J, Rudi Westendorp G, James Shepherd, Barry Davis R, Sara Pressel L, Roberto Marchioli, Rosa Maria Marfisi, Aldo Maggioni P, Luigi Tavazzi, Gianni Tognoni, John Kjekshus, et al. Lancet 2010 375 9716 735 42 10.1016/S0140- 6736(09)61965-6 20167359
36. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Cholesterol Treatment Trialists' (CTT) Collaboration, Baigent C, Blackwell L, Emberson J, Holland LE, Reith C, Bhala N, Peto R, Barnes EH, Keech A, Simes J, Collins R, Lancet 2010 376 9753 1670 81 10.1016/S0140-6736(10)61350-5 21067804